Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Body Movements Analysis During Sleep in Very Premature Infants (DODOPREMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03432182
Recruitment Status : Recruiting
First Posted : February 14, 2018
Last Update Posted : September 16, 2021
Sponsor:
Information provided by (Responsible Party):
Jean-Michel HASCOET, Central Hospital, Nancy, France

Brief Summary:
Sleep is a key factor for normal brain development of the newborn. However, it is poorly studied and little is known about its characterization, especially in premature infants. Body movements during sleep are easy to evaluate but studies on their relationship to normal sleep states are scarce and limited. This project aims to characterize body movements during sleep, assessed by electroencephalography, in very premature infants. Then, a correlation between body movements, sleep organization and neurodevelopmental outcome will be evaluated at 3 years of age.

Condition or disease Intervention/treatment Phase
Sleep Diagnostic Test: electroencephalography Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Characterization of Movements Occurring During Sleep in Very Premature Neonates: Relationship With Neurodevelopmental Outcome
Actual Study Start Date : February 28, 2018
Estimated Primary Completion Date : June 30, 2023
Estimated Study Completion Date : December 31, 2025

Arm Intervention/treatment
very premature infants
Electroencephalography allowing sleep observation
Diagnostic Test: electroencephalography
Sleep states definition by electroencephalograpy




Primary Outcome Measures :
  1. Body movements evaluation during sleep [ Time Frame: 3 months ]
    number of movements observed according to sleep states


Secondary Outcome Measures :
  1. Sleep states organization [ Time Frame: 3 months ]
    sleep states characterization by electroencephalography according to postmenstrual age

  2. Type of movements observed during sleep [ Time Frame: 3 months ]
    Movements characterization according to sleep states

  3. Neurodevelopmental outcome [ Time Frame: 3 years ]
    neuropsychomotor evaluation by Bayley psychometric test



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 15 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Infants born between 26 and 32 weeks gestation

Exclusion Criteria:

  • Genetic abnormality
  • Neurological pathology such as intraventricular hemorrhage > grade 2
  • Any medication know for altering electroencephalography recording

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03432182


Contacts
Layout table for location contacts
Contact: Jean-Michel HASCOET, MD +33 383 342 934 j.hascoet@chru-nancy.fr
Contact: Laurelia JOURDAN +33 383 343 645 l.jourdan@chru-nancy.fr

Locations
Layout table for location information
France
Maternity Hospital CHRU Recruiting
Nancy, France, 54035
Contact: Jean-Michel HASCOET    383342934    j.hascoet@chru-nancy.fr   
Sponsors and Collaborators
Central Hospital, Nancy, France
Layout table for additonal information
Responsible Party: Jean-Michel HASCOET, Principal Investigator, Central Hospital, Nancy, France
ClinicalTrials.gov Identifier: NCT03432182    
Other Study ID Numbers: 2017-A02687-46
First Posted: February 14, 2018    Key Record Dates
Last Update Posted: September 16, 2021
Last Verified: September 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Jean-Michel HASCOET, Central Hospital, Nancy, France:
Premature infant
sleep state
body movement
neurodevelopmental outcome
Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications